The Effects of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors on P-Glycoprotein Expression in Peripheral Blood Mononuclear Cells In Vitro
Viral Dynamics and Their Relations to Baseline Factors and Longer Term Virologic Responses in Treatment-Naive HIV-1-Infected Patients Receiving Abacavir in Combination with HIV-1 Protease Inhibitors
Leptin Replacement Therapy But Not Dietary Polyunsaturated Fatty Acid Alleviates HIV Protease Inhibitor-Induced Dyslipidemia and Lipodystrophy in Mice
An Objective Lipodystrophy Severity Grading Scale Derived From the Lipodystrophy Case Definition Score
The Effect of HAART and HCV Infection on the Development of Hyperglycemia Among HIV-Infected Persons
Progression of HIV Disease Among Women Following Delivery
Lopinavir Plasma Concentrations and Changes in Lipid Levels During Salvage Therapy with Lopinavir/Ritonavir-Containing Regimens
Interleukin-7 and Immunologic Failure Despite Treatment with Highly Active Antiretroviral Therapy in Children Perinatally Infected with HIV-1
Effect of Antioxidants on Glucose Metabolism and Plasma Lipids in HIV-Infected Subjects With Lipoatrophy
Contraception Use, Family Planning, and Unprotected Sex: Few Differences Among HIV-Infected and Uninfected Postpartum Women in Four US States
Clinical and Immunologic Progression in HIV-Infected US Women Before and After the Introduction of Highly Active Antiretroviral Therapy
Performance Characteristics of a New Less Sensitive HIV-1 Enzyme Immunoassay for Use in Estimating HIV Seroincidence
Are There Gender and Race Differences in Cellular Immunity Patterns Over Age in Infected and Uninfected Children Born to HIV-Infected Women?
The Value of Screening for Sexually Transmitted Diseases in an HIV Clinic
Letter to the Editor: High Prevalence of HIV Infection Among Women and Their Children in Henan Province, China
Letters to the Editor: Lack of Methadone Dose Alterations or Withdrawal Symptoms During Therapy With Lopinavir/Ritonavir
Pilot Study of Directly Observed Therapy in Highly Nonadherent HIV-Infected Patients in an Urban Community-Based Institution
Changes in Metabolic Profile Among Antiretroviral-Naive Patients Initiating Protease Inhibitor Versus Non-Protease Inhibitor Containing HAART Regimens
Increased Human T-Lymphotropic Virus Type II Proviral Load Following Highly Active Retroviral Therapy in HIV-Coinfected Patients
Erratum